Project: Arterial spin labelling Scanner- and Patient-Independent Robust diagnostic Evaluation
Acronym | ASPIRE (Reference Number: 113701) |
Duration | 01/05/2020 - 01/01/2024 |
Project Topic | ASPIRE will create a novel imaging biomarker for dementia for diagnosis support. Signs of Alzheimer’s (AD) will be detectable at early stages before clinical manifestation. The solution is based on the non-invasive magnetic resonance imaging (MRI) technique “Arterial Spin Labelling” (ASL) combined with scanner calibration, physiological atlas comparison, and artificial intelligence (AI)-based diagnostic support. The technique will simplify the diagnostic process, reduce cost and patient risk. |
Network | Eurostars 2 |
Call | Eurostars Cut–off 12 |